MacroGenics financial statements

매크로제닉스NASDAQ:MGNX · Nasdaq · Healthcare · sector #17
$3.55-2.47%
2026-10-07 close · prelim

MacroGenics's published financial data is dated 2026-10-04. 2024 revenue was $150M. 2024 operating profit was −$74M.

Reported results

MacroGenics notifications

Quantus Signal · live data · not investment advice · Privacy Policy